Data from Pharmawand - Curated by EPG Health - Date added 09 February 2019
New research published in a diabetes technology journal shows the long-term clinical accuracy of the OneTouch blood glucose test strip platform, from J&J Life Scan, and highlights the products' consistently accurate performance. This is the latest study in a series of recent studies that confirm the OneTouch brand blood glucose monitoring system accuracy.
A study published in the Journal of Diabetes Science and Technology (JDST) details the OneTouch Select Plus blood glucose monitoring platform's three years of proven accuracy across multiple clinical studies in patients with diabetes. The study results were derived from more than 21,000 data points from over 200 different test strip batches released since the launch of the OneTouch Select Plus test strip in 2015. Results show that the system consistently met the minimum requirements of the International Organization for Standardization (ISO) standard 15197:2013 and the European harmonized version EN ISO 15197:2015, with an average of 97.6% of results within specification, demonstrating both product accuracy and consistency.
This study follows the publication of a third study in the April 2017 issue of the same journal that detailed the OneTouch Verio platform's seven years of proven accuracy across more than 70,000 clinical data points.
See: "Evidence from a Long-term, Systematic Post-Market Surveillance Program; Clinical Performance of a Haematocrit Insensitive Blood Glucose Test-Strip." Setford, et al. Journal of Diabetes Science and Technology (2019) 1-9